Author:
Cheng Wen,Liao Yang,Mou Ruiyu,Xiao Xian,Jia Yingjie
Abstract
BackgroundPrevious epidemiological observational studies have reported an association between inflammatory bowel disease (IBD) and prostate cancer (PCa), but the causality is inconclusive. The purpose of this study was to evaluate the causality of IBD on PCa using the mendelian randomization (MR) analysis.MethodsWe performed a two-sample MR analysis with public genome-wide association studies (GWAS) data. Eligible instrumental variables (IVs) were selected according to the three assumptions of MR analysis. The inverse-variance weighted (IVW) method was the main method. Complementary methods included the MR-Egger regression, the Weighted Median, the Simple Mode, the Weighted Mode and MR pleiotropy residual sum and outlier (MR-PRESSO) methods.ResultsGenetically determined IBD did not have a causal effect on PCa (IVW P > 0.05). Additionally, there was no causal effect of Crohn’s disease (CD) and ulcerative colitis (UC) on PCa in the MR analysis (IVW P > 0.05). Results of complementary methods were consistent with those of the IVW method.ConclusionsThis study does not support a causal association of IBD on PCa, which is in contrast to most observational studies.
Subject
Immunology,Immunology and Allergy
Reference34 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Global trends of latent prostate cancer in autopsy studies;Kimura;Cancers (Basel),2021
3. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019;Zi;Mil Med Res,2021
4. Epidemiology and prevention of prostate cancer;Gandaglia;Eur Urol Oncol,2021
5. The causal relationships between extrinsic exposures and risk of prostate cancer: a phenome-wide mendelian randomization study;Gu;Front Oncol,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献